Lindner Magdalena, Gosewisch Astrid, Eilles Eva, Branner Christina, Krämer Anja, Oos Rosel, Wolf Eckhard, Ziegler Sibylle, Bartenstein Peter, Brandt Thomas, Dieterich Marianne, Zwergal Andreas
German Center for Vertigo and Balance Disorders, DSGZ, Ludwig-Maximilians-University of Munich, Munich, Germany.
Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
Front Neurol. 2019 Feb 25;10:147. doi: 10.3389/fneur.2019.00147. eCollection 2019.
Unilateral inner ear damage is followed by behavioral recovery due to central vestibular compensation. The dose-dependent therapeutic effect of extract EGb 761 on vestibular compensation was investigated by behavioral testing and serial cerebral [F]-Fluoro-desoxyglucose ([F]-FDG)-μPET in a rat model of unilateral labyrinthectomy (UL). Five groups of 8 animals each were treated with EGb 761-supplemented food at doses of 75, 37.5 or 18.75 mg/kg body weight 6 weeks prior and 15 days post UL (groups A,B,C), control food prior and EGb 761-supplemented food (75 mg/kg) for 15 days post UL (group D), or control food throughout (group E). Plasma levels of EGb 761 components bilobalide, ginkgolide A and B were analyzed prior and 15 days post UL. Behavioral testing included clinical scoring of nystagmus, postural asymmetry, head roll tilt, body rotation during sensory perturbation and instrumental registration of mobility in an open field before and 1, 2, 3, 5, 7, 15 days after UL. Whole-brain [F]-FDG-μPET was recorded before and 1, 3, 7, 15 days after UL. The EGb 761 group A (75 mg/kg prior/post UL) showed a significant reduction of nystagmus scores (day 3 post UL), of postural asymmetry (1, 3, 7 days post UL), and an increased mobility in the open field (day 7 post UL) as compared to controls (group E). Application of EGb 761 at doses of 37.5 and 18.75 mg/kg prior/post UL (groups B,C) resulted in faster recovery of postural asymmetry, but did not influence mobility relative to controls. Locomotor velocity increased with higher plasma levels of ginkgolide A and B. [F]-FDG-μPET revealed a significant decrease of the regional cerebral glucose metabolism (rCGM) in the vestibular nuclei and cerebellum and an increase in the hippocampal formation with higher plasma levels of ginkgolides and bilobalide 1 and 3 days post UL. Decrease of rCGM in the vestibular nucleus area and increase in the hippocampal formation with higher plasma levels persisted until day 15 post UL. In conclusion, extract EGb 761 improves vestibulo-ocular motor, vestibulo-spinal compensation, and mobility after UL. This rat study supports the translational approach to investigate EGb 761 at higher dosages for acceleration of vestibular compensation in acute vestibular loss.
由于中枢前庭代偿,单侧内耳损伤后行为会恢复。通过行为测试和连续脑[F]-氟脱氧葡萄糖([F]-FDG)-微正电子发射断层扫描(μPET),在单侧迷路切除术(UL)大鼠模型中研究了EGb 761提取物对前庭代偿的剂量依赖性治疗效果。五组,每组8只动物,在UL前6周和UL后15天分别给予含75、37.5或18.75 mg/kg体重EGb 761的食物(A、B、C组),UL前给予对照食物,UL后15天给予含EGb 761(75 mg/kg)的食物(D组),或全程给予对照食物(E组)。分析UL前和UL后15天EGb 761成分白果内酯、银杏内酯A和B的血浆水平。行为测试包括眼球震颤的临床评分、姿势不对称、头部侧倾、感觉扰动期间的身体旋转以及在开放场地中UL前和UL后1、2、3、5、7、15天移动性的仪器记录。在UL前和UL后1、3、7、15天记录全脑[F]-FDG-μPET。与对照组(E组)相比,EGb 761 A组(UL前后75 mg/kg)在UL后3天眼球震颤评分显著降低,在UL后1、3、7天姿势不对称显著降低,在开放场地中UL后7天移动性增加。在UL前后给予37.5和18.75 mg/kg剂量的EGb 761(B、C组)导致姿势不对称恢复更快,但相对于对照组对移动性没有影响。运动速度随着银杏内酯A和B血浆水平升高而增加。[F]-FDG-μPET显示,在UL后1和3天,前庭核和小脑中区域脑葡萄糖代谢(rCGM)显著降低,海马结构中rCGM增加;银杏内酯和白果内酯血浆水平较高时,前庭核区域rCGM降低和海马结构增加持续至UL后15天。总之,EGb 761提取物可改善UL后的前庭眼动、前庭脊髓代偿和移动性。这项大鼠研究支持采用转化方法研究更高剂量的EGb 761,以加速急性前庭丧失中的前庭代偿。